科源制药：第四届董事会第十一次会议决议公告

Group 1 - The company announced the approval of multiple proposals during the 11th meeting of the 4th Board of Directors, including adjustments to the plan for issuing shares to purchase assets and raising matching funds, which do not constitute a significant change to the transaction plan [2]